BHST · Bioharvest Sciences Inc. · Metrics
Market Cap
$41.94M
Shares
22.67M
BHST metrics
45 of 115 screener metrics currently available.
Market overview
2 metricsShare price
$1.85
Market cap
$41.94M
Price action
20 metricsPrice change (1W)
+1.6%
Price change (30D)
-10.6%
Price change (3M)
-42.2%
Price change (6M)
-55.4%
Price change (YTD)
-64.4%
Price change (1Y)
-74.8%
Trailing year
Price change (5Y)
-83.2%
52-week high
$12.65
52-week low
$1.80
Change from 52-week high
-85.4%
Change from 52-week low
+2.8%
Annualized volatility
77.2%
Annualized volatility (3M)
72.3%
Beta
1.0
RSI (14D)
37.9
Price vs SMA 50
-17.2%
Price vs SMA 200
-53.2%
Avg volume (3M)
51,556
Relative volume
0.6
Average dollar volume
$118,695
Company
3 metricsSector
Consumer Defensive
Industry
Packaged Foods
Shares outstanding
22.67M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
1.6
reciprocal yield 60.7%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
—
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-08-11
Profitability
9 metricsGross margin
59.3%
Operating margin
-16.2%
Trailing 12 months
Net margin
-32.3%
Gross profit (TTM)
—
Operating profit (TTM)
—
Net income (TTM)
—
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
+37.0%
Year over year
Net income growth YoY
—
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+30.8%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
-43.8%
Return on assets
-23.4%
Debt / equity
—
Current ratio
4.0
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
3.4
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$23.02M
Total assets
$47.66M
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
—
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—
Ownership (13F)
3 metrics13F filers
19
13F filer change QoQ
-1
Institutional ownership
7.4%
Short interest
3 metricsShort interest
0.3%
Latest settlement · 2.0 days to cover
Days to cover
2.0d
Short-squeeze score
44 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—